Stay updated on Combination Therapy in Relapsed Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Combination Therapy in Relapsed Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Combination Therapy in Relapsed Multiple Myeloma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-20T05:51:19.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The site footer now identifies the release as v3.7.1 instead of v3.7.0. The study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-13T08:14:56.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    The study record now displays a 403 Forbidden error page with updated site chrome including a Home link and a Revision: v3.7.0 note, effectively blocking access to the trial details. Sponsor-related content and links (AbbVie, IPD sharing, SAP, study documents, and related materials) were removed, altering the core context and availability of the trial information.
    Difference
    22%
    Check dated 2026-09-22T05:59:48.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    A new revision label appears on the page: Revision: v3.6.6, indicating a minor update to the page template or site platform.
    Difference
    0.0%
    Check dated 2026-08-31T23:14:35.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The page adds a funding note—'2017 ( U.S. NIH Grant/Contract )'—and removes the disease tag 'Multiple myeloma' along with the related topic 'MedlinePlus Genetics', altering the study's tagging and related topics shown.
    Difference
    0.1%
    Check dated 2026-08-24T22:20:10.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Multiple myeloma is now listed under related topics, and MedlinePlus Genetics is added as a related topic resource. This enhances disease context and provides quick access to genetic background information for readers.
    Difference
    0.1%
    Check dated 2026-08-17T20:57:42.000Z thumbnail image

Stay in the know with updates to Combination Therapy in Relapsed Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Combination Therapy in Relapsed Multiple Myeloma Clinical Trial page.